Literature DB >> 31415864

Pathways to functional outcomes in schizophrenia spectrum disorders: Meta-analysis of social cognitive and neurocognitive predictors.

Tate F Halverson1, Maku Orleans-Pobee1, Carrington Merritt1, Paschal Sheeran1, Anne-Kathrin Fett2, David L Penn3.   

Abstract

The current meta-analysis explored relationships between functional outcomes in schizophrenia spectrum disorders and different domains of neurocognition and social cognition. Literature searches were conducted in PsycINFO, PubMed, and ProQuest to identify articles reporting correlations between cognition domains and functional outcomes. Of 1361 articles identified, 166 met all inclusion criteria (12,868 participants; 518 correlations). Fifty-three random-effects meta-analyses yielded mean correlation estimates for relationships between neurocognition and social cognition and functional outcomes. Overall, associations between social cognition and neurocognition, and functional outcomes demonstrated significant small-to-medium effect sizes. Social cognition explained more unique variance in functioning than neurocognition (7.3% vs. 4.4%; 9.2% total average variance). Social cognition also mediated the relationship between neurocognition and functional outcomes. A significant proportion of the variance in the relationships between cognition and functional outcomes remained unexplained. These findings suggest that integrated interventions targeting both neurocognition and social cognition may optimally improve functional outcomes. Standardized measurement of cognition and functioning, longitudinal studies, and tests of additional moderators (e.g., first episode samples) in future research were identified as important future directions.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Community functioning; Functional outcome; Neurocognition; Psychosis; Quality of life; Schizophrenia; Social cognition

Mesh:

Year:  2019        PMID: 31415864     DOI: 10.1016/j.neubiorev.2019.07.020

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  33 in total

1.  Mentalizing Errors in Patients with Schizophrenia Who Received Psychosocial Rehabilitation: a Case-Control Study.

Authors:  Nelson Andrade-González; Miriam Sarasa; Araceli García-López; Israel Leonés; Tate F Halverson; Guillermo Lahera
Journal:  Psychiatr Q       Date:  2021-01-06

2.  Positive schizotypy is associated with amplified mnemonic discrimination and attenuated generalization.

Authors:  Ágota Vass; Melinda Becske; Ágnes Szőllősi; Mihály Racsmány; Bertalan Polner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-27       Impact factor: 5.270

3.  Social cognition, neurocognition, symptomatology, functional competences and outcomes in people with schizophrenia - A network analysis perspective.

Authors:  Michal Hajdúk; David L Penn; Philip D Harvey; Amy E Pinkham
Journal:  J Psychiatr Res       Date:  2021-09-24       Impact factor: 4.791

4.  European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Andreas Erfurth; Stefano Barlati; Federico Zanca; Giulia Maria Giordano; Louise Birkedal Glenthøj; Merete Nordentoft; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

Review 5.  European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia.

Authors:  Antonio Vita; Wolfgang Gaebel; Armida Mucci; Gabriele Sachs; Stefano Barlati; Giulia Maria Giordano; Gabriele Nibbio; Merete Nordentoft; Til Wykes; Silvana Galderisi
Journal:  Eur Psychiatry       Date:  2022-09-05       Impact factor: 7.156

6.  A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits.

Authors:  Qiannan Zhao; Hengyi Cao; Wenjing Zhang; Siyi Li; Yuan Xiao; Carol A Tamminga; Matcheri S Keshavan; Godfrey D Pearlson; Brett A Clementz; Elliot S Gershon; Scot Kristian Hill; Sarah K Keedy; Elena I Ivleva; Rebekka Lencer; John A Sweeney; Qiyong Gong; Su Lui
Journal:  Neuropsychopharmacology       Date:  2022-03-08       Impact factor: 8.294

7.  A Meta-analysis of Cognitive Remediation for Schizophrenia: Efficacy and the Role of Participant and Treatment Factors.

Authors:  Julia A Lejeune; Andrew Northrop; Matthew M Kurtz
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

8.  Functional Impairments and Theory of Mind Deficits in Schizophrenia: A Meta-analysis of the Associations.

Authors:  Élisabeth Thibaudeau; Caroline Cellard; Mélissa Turcotte; Amélie M Achim
Journal:  Schizophr Bull       Date:  2021-04-29       Impact factor: 9.306

9.  Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder.

Authors:  Flurin Cathomas; Karoline Guetter; Federica Klaus; Stefan Kaiser; Erich Seifritz
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

10.  Outcome prediction with a social cognitive battery: a multicenter longitudinal study.

Authors:  Eric Brunet-Gouet; Capucine Decaix-Tisserand; Mathieu Urbach; Nadine Bazin; Bruno Aouizerate; Lore Brunel; Delphine Capdevielle; Isabelle Chereau; Caroline Dubertret; Julien Dubreucq; Guillaume Fond; Christophe Lançon; Sylvain Leignier; Jasmina Mallet; David Misdrahi; Sylvie Pires; Priscille Schneider; Franck Schurhoff; Hanan Yazbek; Anna Zinetti-Bertschy; Christine Passerieux; Paul Roux
Journal:  NPJ Schizophr       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.